UK markets close in 2 hours 24 minutes

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.32-0.52 (-5.28%)
At close: 04:00PM EDT
9.76 +0.44 (+4.72%)
After hours: 07:18PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-99,339
-96,655
-104,787
-71,096
-22,121
Depreciation & amortisation
365
377
357
163
11
Stock-based compensation
17,535
17,256
18,829
15,913
3,108
Change in working capital
248
-589
3,022
2,830
-1,505
Accounts payable
6,975
2,324
351
-683
-220
Other working capital
-86,985
-83,727
-82,428
-52,265
-19,922
Other non-cash items
-5,752
-4,227
514
1,224
641
Net cash provided by operating activities
-86,832
-83,727
-82,065
-50,690
-19,866
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-363
-1,575
-56
Purchases of investments
-307,343
-255,625
-213,660
-486,967
0
Sales/maturities of investments
245,100
250,760
305,502
213,104
0
Net cash used for investing activities
-62,382
-4,851
91,479
-275,438
-56
Cash flows from financing activities
Common stock issued
137,637
129,736
0
0
220,550
Common stock repurchased
-
-
-
0
-2,289
Net cash used provided by (used for) financing activities
142,016
133,415
476
1,391
358,403
Net change in cash
-7,198
44,837
9,890
-324,737
338,481
Cash at beginning of period
40,918
23,702
13,812
338,549
68
Cash at end of period
33,720
68,539
23,702
13,812
338,549
Free cash flow
Operating cash flow
-86,832
-83,727
-82,065
-50,690
-19,866
Capital expenditure
-
-
-363
-1,575
-56
Free cash flow
-86,985
-83,727
-82,428
-52,265
-19,922